NASDAQ:MRNS

Delisted

Marinus Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy MRNS

*Your capital is at risk

$0.550

+0 (+0%)

At Close: May 09, 2025

Marinus Pharmaceuticals to Present at the 38th Annual J.P. Morgan Global Healthcare Conference

12:30pm, Tuesday, 07'th Jan 2020

RADNOR, Pa., Jan. 07, 2020 -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of.

38 Healthcare Stocks Moving In Monday's Pre-Market Session

12:00am, Monday, 30'th Dec 2019

18 Stocks Moving in Thursday's Pre-Market Session

12:35pm, Thursday, 26'th Dec 2019

20 Stocks Moving in Monday's Pre-Market Session

12:00am, Monday, 23'rd Dec 2019

Marinus Pharmaceuticals shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per share.

12:00am, Friday, 20'th Dec 2019

Marinus Pharma Shares Indicated Up 9% After Hours As Hearing Oppenheimer Initiates Coverage On Stock With Outperform Rating, $6 Price Target

12:00am, Thursday, 19'th Dec 2019

Marinus Pharmaceuticals Announces Closing of $7… Million Public Offering of Common Stock and ...

12:00am, Friday, 13'th Dec 2019

70 Biggest Movers From Yesterday

12:00am, Thursday, 12'th Dec 2019

The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint

12:21pm, Wednesday, 11'th Dec 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 10) Acceleron Pharma Inc (NASDAQ: XLRN ) Aimmune Thera

Mid-Afternoon Market Update: Federal Reserve Maintains Interest Rates; United Natural Foods Shares Fall On Downbeat Earnings

12:00am, Wednesday, 11'th Dec 2019

Marinus Pharmaceuticals shares are trading lower after the company announced a common stock offering with no size disclosed.

12:00am, Tuesday, 10'th Dec 2019

Marinus Pharma Gives Updates on its Orphan Epilepsy Program

12:00am, Monday, 09'th Dec 2019

Marinus Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.

12:00am, Thursday, 05'th Dec 2019

Marinus Pharmaceuticals Announces Presentations on Ganaxolone at AES Annual Meeting

12:00am, Wednesday, 27'th Nov 2019

Marinus Shares Tick Higher On Volume As Traders Circulate EC Public Health Notice For Co.'s Ganaxolone

12:00am, Monday, 18'th Nov 2019

Marinus Pharmaceuticals Stock News

Marinus Pharmaceuticals to Present at the 38th Annual J.P. Morgan Global Healthcare Conference

38 Healthcare Stocks Moving In Monday's Pre-Market Session

18 Stocks Moving in Thursday's Pre-Market Session

20 Stocks Moving in Monday's Pre-Market Session

Marinus Pharmaceuticals shares are trading higher after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per share.

Marinus Pharma Shares Indicated Up 9% After Hours As Hearing Oppenheimer Initiates Coverage On Stock With Outperform Rating, $6 Price Target

Marinus Pharmaceuticals Announces Closing of $7… Million Public Offering of Common Stock and ...

70 Biggest Movers From Yesterday

The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint

Mid-Afternoon Market Update: Federal Reserve Maintains Interest Rates; United Natural Foods Shares Fall On Downbeat Earnings

Marinus Pharmaceuticals shares are trading lower after the company announced a common stock offering with no size disclosed.

Marinus Pharma Gives Updates on its Orphan Epilepsy Program

Marinus Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.

Marinus Pharmaceuticals Announces Presentations on Ganaxolone at AES Annual Meeting

Marinus Shares Tick Higher On Volume As Traders Circulate EC Public Health Notice For Co.'s Ganaxolone

Top Fintech Company